ConductScience.org, home

Trial · NCT01495585

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDPlacebo4
Overall StudySTARTEDLonafarnib 100 mg6
Overall StudySTARTEDLonafarnib 200 mg4
Overall StudyOpen Label Lonafarnib 200 mgPlacebo2
Overall StudyOpen Label Lonafarnib 200 mgLonafarnib 100 mg0
Overall StudyOpen Label Lonafarnib 200 mgLonafarnib 200 mg0
Overall StudyCOMPLETEDPlacebo4
Overall StudyCOMPLETEDLonafarnib 100 mg6
Overall StudyCOMPLETEDLonafarnib 200 mg4
Overall StudyNOT COMPLETEDPlacebo0
Overall StudyNOT COMPLETEDLonafarnib 100 mg0
Overall StudyNOT COMPLETEDLonafarnib 200 mg0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01495585/flow